Transcriptomics

Dataset Information

0

Inhibition of CDK8 Mediator Kinase Suppresses Estrogen Receptor Signaling and Growth of Estrogen Receptor Positive Breast Cancer


ABSTRACT: Hormone therapy targeting estrogen receptor (ER) is the principal treatment for ER-positive breast cancers but many cancers develop resistance to anti-estrogens. Cyclin-dependent kinase 8 (CDK8) is a transcriptional regulator of several oncogenic pathways. Expression levels of CDK8 and ERα are inversely correlated in breast cancers suggesting a functional association between CDK8 and ER. CDK8 inhibition by selective small-molecule inhibitors, by shRNA knockdown or by CRISPR-Cas9 knockout suppressed estrogen-induced transcription, with no significant effects on ERα protein expression or phosphorylation. CDK8 inhibition also abrogated the mitogenic effect of estrogen on ER-positive breast cancer cells and potentiated growth inhibition by the ER antagonist fulvestrant. In vivo, administration of a CDK8 inhibitor suppressed ER-positive breast cancer xenograft growth and augmented the effects of fulvestrant with no apparent toxicity. CDK8 inhibitors also suppressed the development of estrogen independence in ER-positive breast cancer cells. These results identify CDK8 as a novel drug target for breast cancer therapy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE93193 | GEO | 2017/02/14

SECONDARY ACCESSION(S): PRJNA360278

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-09-13 | GSE217190 | GEO
2015-08-07 | E-GEOD-71791 | biostudies-arrayexpress
2015-05-02 | E-GEOD-65886 | biostudies-arrayexpress
2019-03-21 | PXD012930 | Pride
2021-10-13 | GSE166168 | GEO
2012-11-02 | E-GEOD-39870 | biostudies-arrayexpress
2015-05-02 | GSE65886 | GEO
2012-11-02 | GSE39870 | GEO
2021-10-13 | GSE173976 | GEO
2012-05-13 | E-GEOD-22533 | biostudies-arrayexpress